Innoviva, Inc. (INVA)
20.96
-0.28
(-1.32%)
USD |
NASDAQ |
Aug 27, 16:00
20.98
+0.02
(+0.10%)
After-Hours: 20:00
Innoviva EPS Diluted (TTM) : 4.105 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.105 |
| March 31, 2026 | 6.014 |
| December 31, 2025 | 3.055 |
| September 30, 2025 | 1.394 |
| June 30, 2025 | 0.3318 |
| March 31, 2025 | -0.9956 |
| December 31, 2024 | 0.2093 |
| September 30, 2024 | 0.6879 |
| June 30, 2024 | 1.653 |
| March 31, 2024 | 2.227 |
| December 31, 2023 | 2.184 |
| September 30, 2023 | 0.4419 |
| June 30, 2023 | 2.261 |
| March 31, 2023 | 2.255 |
| December 31, 2022 | 2.032 |
| September 30, 2022 | 3.140 |
| June 30, 2022 | 1.237 |
| March 31, 2022 | 2.119 |
| December 31, 2021 | 2.762 |
| September 30, 2021 | 3.121 |
| June 30, 2021 | 2.478 |
| March 31, 2021 | 2.27 |
| December 31, 2020 | 2.018 |
| September 30, 2020 | 1.948 |
| June 30, 2020 | 2.051 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.706 |
| December 31, 2019 | 1.43 |
| September 30, 2019 | 3.355 |
| June 30, 2019 | 3.424 |
| March 31, 2019 | 3.571 |
| December 31, 2018 | 3.530 |
| September 30, 2018 | 1.69 |
| June 30, 2018 | 1.47 |
| March 31, 2018 | 1.28 |
| December 31, 2017 | 1.16 |
| September 30, 2017 | 0.9201 |
| June 30, 2017 | 0.8401 |
| March 31, 2017 | 0.6701 |
| December 31, 2016 | 0.5601 |
| September 30, 2016 | 0.34 |
| June 30, 2016 | 0.17 |
| March 31, 2016 | -0.03 |
| December 31, 2015 | -0.16 |
| September 30, 2015 | -0.34 |
| June 30, 2015 | -0.49 |
| March 31, 2015 | -0.99 |
| December 31, 2014 | -1.52 |
| September 30, 2014 | -1.84 |
| June 30, 2014 | -2.09 |
| March 31, 2014 | -1.89 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Zevra Therapeutics, Inc. | 0.927 |
| Collegium Pharmaceutical, Inc. | 1.234 |
| CorMedix, Inc. | 2.105 |
| ANI Pharmaceuticals, Inc. | 4.632 |
| Corcept Therapeutics, Inc. | 0.4187 |